Thrombolytic Therapy for Central Retinal Artery Occlusion in an Academic Multi-Site Stroke Centre

医学 视网膜中央动脉阻塞 溶栓 特奈特普酶 冲程(发动机) 队列 视力 纤溶剂 外科 内科学 组织纤溶酶原激活剂 心肌梗塞 机械工程 工程类
作者
Nour Alhayek,Jacob M. Sobczak,Aimen Vanood,Cumara B. O’Carroll,Bart M. Demaerschalk,John Jing-Wei Chen,Oana M. Dumitrascu
出处
期刊:Neuro-Ophthalmology [Taylor & Francis]
卷期号:48 (2): 111-121 被引量:5
标识
DOI:10.1080/01658107.2023.2290536
摘要

Central retinal artery occlusion (CRAO) is a subtype of acute ischaemic stroke leading to severe visual loss. A recent American Heart Association scientific statement proposed time-windows for thrombolysis in CRAO similar to acute ischaemic cerebral strokes. We aimed to review our academic multi-site stroke centre experience with intravenous (IVT) and intra-arterial thrombolysis (IAT) in CRAO between 1997 and 2022. Demographic, clinical characteristics, thrombolysis timeline, concurrent therapies, complications, and 3-month follow-up visual acuity (VA) were collected. The thrombolysed cohort follow-up VA was compared with an age, gender and baseline VA matched cohort of CRAO patients that received conservative therapies. Thrombolytic therapy was administered to 3.55% (n = 20) of CRAO admissions; 13 IVT (mean age 68, 61.5% male, 12 alteplase and 1 tenecteplase, all embolic aetiology, 1 CRAO mimic) and 7 IAT (mean age 55, 85.7% male, 3 post-operative and 3 embolic). Additional conservative CRAO-targeting therapies was received by 60%. The median time from onset of visual loss to IVT was 158 minutes (range 67–260). Improvement by at least two Snellen lines was achieved by 25% with 12.5% improving to 20/100 or better. Intracranial haemorrhage post IVT occurred in 1/13 (7.6%). The median time from onset of visual loss to IAT was 335 minutes. Improvement by at least two Snellen lines was achieved by 42%. No difference in 3-month VA was noted between patients that received thrombolysis, either alone (n = 8) or combined with other therapies, and those that received conservative therapies. Our results suggest that the management of acute CRAO remains heterogeneous. The lack of obvious benefit of thrombolysis in our small series supports the need for randomizsd clinical trials comparing thrombolysis to placebo to guide hyperacute CRAO management.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
领导范儿的应助被cherish采纳,获得10
刚刚
所所的应助被ihuu采纳,获得10
1秒前
拓跋涵易发布了新的文献求助10
1秒前
完美世界的应助被11111采纳,获得10
1秒前
2秒前
Orange的应助被爱学习的大聪明采纳,获得10
3秒前
3秒前
3秒前
张君发布了新的文献求助10
4秒前
小李发布了新的文献求助10
4秒前
Lemon发布了新的文献求助10
5秒前
7秒前
yang发布了新的文献求助10
7秒前
7秒前
常常嘻嘻发布了新的文献求助10
7秒前
可爱的函函的应助被瓶子君152采纳,获得10
7秒前
今后的应助被跳跃靖采纳,获得10
8秒前
8秒前
马剃天爱星完成签到,获得积分10
9秒前
Ava的应助被WX采纳,获得10
9秒前
9秒前
yy发布了新的文献求助30
9秒前
郭娅楠发布了新的文献求助10
11秒前
11秒前
jimgyi完成签到,获得积分10
11秒前
花花牛不是牛完成签到,获得积分20
11秒前
CipherSage的应助被dan采纳,获得10
12秒前
12秒前
庸人自扰完成签到,获得积分10
12秒前
12秒前
上官若男的应助被Lu采纳,获得10
13秒前
369ninja发布了新的文献求助10
13秒前
007完成签到,获得积分10
13秒前
晚霞跌落星河的应助被tang采纳,获得100
14秒前
yang发布了新的文献求助10
15秒前
16秒前
16秒前
11111发布了新的文献求助10
17秒前
ihuu发布了新的文献求助10
17秒前
柏林发布了新的文献求助10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184267
求助须知:如何正确求助?哪些是违规求助? 9573323
关于积分的说明 21830790
捐赠科研通 7781314
什么是DOI,文献DOI怎么找? 3434307
关于科研通互助平台的介绍 2558389
邀请新用户注册赠送积分活动 2480817